Skip to main content

MacroGenics strikes commercialization deal with Eversana ahead of potential Food and Drug Administration approval for breast cancer treatment – Washington Business Journal

By December 7, 2020News

MacroGenics is led by CEO and co-founder Scott Koenig.
JOANNE S. LAWTON

The agency’s decision is expected to drop Dec. 18.

Image: MacroGenics is led by CEO and co-founder Scott Koenig. JOANNE S. LAWTON

{iframe}https://www.bizjournals.com/washington/news/2020/12/03/macrogenics-locks-in-commercialization-deal-ahead.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.